For instance, our results indicate that the CHRNA9 community was suggested to be implicated in the hepatitis B pathway in five cancers, such as liver hepatocellular carcinoma (LIHC; pink) and KIRC (light blue). Here, CHRNA9 is linked to hepatitis B virus infection.